Primary chemotherapy in locally advanced breast cancer (LABC): effects on tumour proliferative activity, bcl-2 expression and the relationship between tumour regression and biological markers
- 31 October 1998
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 34 (11) , 1701-1704
- https://doi.org/10.1016/s0959-8049(98)00213-5
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Sequential assessment of multidrug resistance phenotype and measurement of S-phase fraction as predictive markers of breast cancer response to neoadjuvant chemotherapyCancer, 1996
- The Bcl-2 Protein: a Prognostic Indicator Strongly Related to p53 Protein in Lymph Node-Negative Breast Cancer PatientsJNCI Journal of the National Cancer Institute, 1994
- Relationship of variations in tumor cell kinetics induced by primary chemotherapy to tumor regression and prognosis in locally advanced breast cancerBreast Cancer Research and Treatment, 1994
- Prognostic significance of proliferative activity and ploidy in node-negative breast cancersAnnals of Oncology, 1993
- Cell cycle modifications of breast cancers during neoadjuvant chemotherapy: a flow cytometry study on fine needle aspiratesEuropean Journal Of Cancer, 1993
- Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast CancersJNCI Journal of the National Cancer Institute, 1992
- DNA flow cytometry and response to preoperative chemotherapy for primary breast cancerEuropean Journal Of Cancer, 1992
- Changes in cell kinetics induced by primary chemotherapy in breast cancerInternational Journal of Cancer, 1991
- Cell kinetics as a prognostic indicator in node-negative breast cancerEuropean Journal of Cancer and Clinical Oncology, 1989
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958